Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency

Blood

Volumn 84, Issue 11, 1994, Pages 3936-3947

  Van Leeuwen, J E M ^b   Van Tol, M J D ^b   Joosten, A M ^b   Schellekens, P T A ^b   Langlois Van Den Bergh, R ^b   Waaijer, J L M ^b   Oudeman Gruber, N J ^b   Van Der Weijden Ragas, C P M ^b   Roos, M T L ^b   Gerritsen, E J A ^b   Van Den Berg, H ^b   Haraldsson, A ^b   Meera Khan, P ^b   Vossen, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CHILD; CHIMERA; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; GENE AMPLIFICATION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE;

EID: 0027939098     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.11.3936.bloodjournal84113936     Document Type: Article

References (72)

1. Fischer A: Severe combined immunodeficiencies. Immunodef Rev 3:83, 1992
2. Dooren LJ, Vossen JM: Severe combined immunodeficiency: Reconstitution of the immune system following bone marrow transplantation, in van Bekkum DW, Löwenberg B (eds): Bone Marrow Transplantation. Biological Mechanisms and Clinical Practice. New York, NY, Dekker, 1985, p 351
3. Gatti RA, Allen HD, Meeuwissen HJ, Hong R, Good RA: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366, 1968
4. de Koning J, Dooren LJ, van Bekkum DW, van Rood JJ, Dicke KA, Radl J: Transplantation of bone marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet 1:1223, 1969
5. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good RA, O'Reilly RJ: Transplantation for severe combined immunodeficiency with HLAA,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341, 1983
6. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen EJA, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky RJ, Vossen JM: European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 336:850, 1990
7. O'Reilly RJ, Keever CA, Small TN, Brochstein JA: The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodef Rev 1:273, 1989
8. van Leeuwen JEM, van Tol MJD, Bodzinga BG, Wijnen JT, van der Keur M, Joosten AM, Tanke HJ, Vossen JM, Meera Khan P: Detection of mixed chimaerism in flow sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation. Br J Haematol 79:218, 1991
9. van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Meera Khan P, Vossen JM: Mixed T lymphoid chimerism following allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 82:1921, 1993
10. Löwenberg B, Vossen JM, Dooren LJ: Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease. Blut 34:181, 1977
11. Rosen FS, Wedgwood RJ, Eibl M, Griscelli C, Seligmann M, Aiuti F, Kishimoto T, Matsumoto S, Khakhalin LN, Hanson LA, Hitzig WH, Thompson RA, Cooper MD, Good RA, Waldmann TA: Primary immunodeficiency diseases. Report of a WHO scientific group. Immunodef Rev 3:195, 1992
12. Thompson A, Hendriks RW, Kraakman MEM, Koning F, Langlois van den Bergh R, Vossen JM, Weemaes CMR, Schuurman RKB: Severe combined immunodefiency in man with an absence of immunoglobulin gene rearrangements but normal T cell receptor assembly. Eur J Immunol 20:2051, 1990
13. Nezelof C: Thymic dysplasia with normal immunoglobulins and immunologic deficiency: Pure alymphocytosis, in Bergsma D, Good RA (eds): Birth Defects. Original Article Series. Immunological Deficiency Diseases in Man (ed 4). New York, NY, Liss, 1968, p 104
14. Gerritsen EJA, Vossen JM, van Tol MJD, Jol-van der Zijde CM, van der Weijden-Ragas CPM, Radl J: Monoclonal gammopathies in children. J Clin Immunol 9:296, 1989
15. Kuis W, Roord JJ, Zegers BJM, Schuurman RKB, Heijnen CJ, Baldwin WM, Goulmy E, Claas F, van de Griend RJ, Rijkers GT, van Rood JJ, Vossen JM, Ballieux RE, Stoop JW: Clinical and immunological studies in a patient with the "bare lymphocyte" syndrome, in Touraine JL, Gluckman E, Griscelli C (eds): Bone Marrow Transplantation in Europe, vol 2. Amsterdam, The Netherlands, Excerpta Medica, 1981, p 201
16. Schuurman HJ, van de Wijngaert FP, Huber J, Schuurman RKB, Zegers BJM, Roord JJ, Kater L: The thymus in "bare lymphocyte" syndrome: Significance of expression of major histocompatibility complex antigens on thymic epithelial cells in intrathymic T-cell maturation. Hum Immunol 13:69, 1985
17. Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression in MHC class II genes. Immunodef Rev 1:135, 1989
18. Omenn GS: Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427, 1965
19. Barth RF, Vergara VE, Khurana SK, Lonman JT: Rapidly fatal familial histiocytosis associated with eosinophilia and primary immunological deficiency. Lancet 1:503, 1972
20. +, Vβ3-expressing, cytotoxic T lymphocytes in the peripheral blood. J Immunol 149:3403, 1992
21. Fasth A, Porras O, Friedrich W, Morgan G, Levinsky RJ, Hale G: Haploidentical bone marrow transplantation for immunodeficiency. In vivo conditioning with monoclonal antibodies. J Cell Biochem 12:99, 1988 (abstr)
22. Fischer A, Friedrich W, Fasth A, Blanche S, Le Deist F, Girault D, Veber F, Vossen JM, Lopez M, Griscelli C, Hirn M: Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immmunodeficiencies, osteopetrosis, and Fanconi's anemia: A European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 77:249, 1991
23. Dicke KA, van Bekkum DW: Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation. Transplant Proc 3:666, 1971
24. Wagemaker G, Heidt PJ, Merchav S, van Bekkum DW: Abrogation of histocompatibility barriers to bone marrow transplantation in rhesus monkeys, in Baum SJ, Ledney GD, Thierfelder S (eds): Experimental Hematology Today. Basel, Switzerland, Karger, 1982, p 111
25. Waldmann H, Polliak A, Hale G, Or R, Cividalli G, Weiss L, Weshler Z, Samual S, Manor D, Brautbar C, Rachmilewitz EA, Slavin S: Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1). Lancet 2:483, 1984
26. Storb R, Epstein RB, Graham TG, Thomas ED: Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9:240, 1970
27. Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJA, Hermans J, Dooren LJ: Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 9:14, 1990
28. van den Berg H, Vossen JM, Langlois van den Bergh R, Bayer J, van Tol MJD: Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two color immunofluorescence. Lab Invest 64:623, 1991
29. Korver K, de Lange G, Langlois van den Bergh R, Schellekens PTA, van Loghem E, van Leeuwen F, Vossen JM: Lymphoid chimerism after allogeneic bone-marrow transplantation: Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins. Transplantation 44:643, 1987
30. Gerritsen EJA, van Tol MJD, Lankester AC, van der WeijdenRagas CPM, Jol-van der Zijde CM, Oudeman-Gruber NJ, Radl J, Vossen JM: Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 82:3493, 1993
31. Bloemena E, Roos MTL, van Heyst JLAM, Vossen JM, Schellekens PTA: Whole-blood lymphocyte cultures. J Immunol Methods 122:161, 1989
32. ten Berge RJM, Schellekens PTA, Budding-Koppenol A, Dooren LJ, Vossen JM: Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency. J Clin Immunol 7:198, 1987
33. Vossen JM, de Koning J, van Bekkum DW, Dicke KA, Eysvoogel VP, Hijmans W, van Loghem E, Radl J, van Rood JJ, van der Waay D, Dooren LJ: Successful treatment of an infant with severe combined immunodeficiency by transplantation of hone marrow cells from an uncle. Clin Exp Immunol 13:9, 1973
34. Gerritsen EJA, van Tol MJD, van't Veer MB, Wels JMA, Khouw IMSL, Touw CR, Jol-van der Zijde CM, Hermans J, Rümke HC, Radl J, Vossen JM: Clonal disregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood (in press)
35. Fischer A, Landais P, Friedrich W, Gerritsen EJA, Fasth A, Porta F, Vellodi A, Benkerrou M, Jais JP, Cavazzana-Calvo M, Souillet G, Bordigoni P, Morgan G, van Dijken P, Vossen JM, Locatelli F, Di Bartolomeo P: Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: A report from the European Group for BMT and the European Group for Immunodeficiency. Blood 83:1149, 1994
36. van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Verweij PJM, Meera Khan P, Vossen JM: Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is related to the intensity of the conditioning regimen and/or the recipient age, but not associated with an increased risk of relapse. Blood 83:3059, 1994
37. Grochow LB, Krivit W, Whitley CB, Blazar B: Busulfan disposition in children. Blood 75:1723, 1990
38. Wijnaendts L, Le Deist F, Griscelli C, Fischer A: Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 74:2212, 1989
39. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE: Development of immunity in human severe primary T cell deficiency following haploidentical hone marrow stem cell transplantation. J Immunol 136:2398, 1986
40. Peter HH, Friedrich W, Dopfer R, Muller W, Kortmann C, Pichler WJ, Heinz F, Rieger CHL: NK cell function in severe combined immunodeficiency (SCID): Evidence of a common T and NK cell defect in some but not all SCID patients. J Immunol 131:2332, 1983
41. Wengler GS, Allen RC, Parolini O, Smith H, Conley ME: Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. J Immunol 150:700, 1993
42. Fischer A, Durandy A, De Villartay JP, Vilmer E, Le Deist F, Gerota I, Griscelli C: HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporin. Blood 67:444, 1986
43. Gougeon ML, Drean G, Le Deist F, Dousseau M, Fevrier M, Diu A, Theze J, Griscelli C, Fischer A: Human severe combined immunodeficiency disease. Phenotypical and functional characteristics of peripheral B lymphocytes. J Immunol 145:2873, 1990
44. Conley ME, Lavoie A, Briggs C, Brown P, Guerra C, Puck JM: Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci 85:3090, 1988
45. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993
46. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262:1877, 1993
47. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Paul WE, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262:1880, 1993
48. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai KI, Sugamura K: Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874, 1993
49. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa SI, Sugamura K: Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453, 1994
50. Friedrich W, Knobloch C, Greher J, Hartmann W, Peter HH, Goldmann SF, Kleihauer E: Bone marrow transplantation in severe combined immunodeficiency: Potential and current limitations. Immunodef Rev 4:315, 1993
51. Singer A, Hathcock KS, Hodes RJ: Self recognition in allogeneic radiation bone marrow chimeras. J Exp Med 153:1286, 1981
52. Sprent J, Lo D, Gao EK, Ron Y: T cell selection in the thymus. Immunol Rev 101:173, 1988
53. Lo D, Sprent J: Identity of cells that imprint H-2-restricted T-cell specificity in the thymus. Nature 319:672, 1986
54. + T cells. Science 244:214, 1989
55. Benoist CO, Mathis D: Positive selection of the T cell repertoire: Where and when does it occur. Cell 58:1027, 1989
56. Hugo P, Kappler JW, Godfrey DI, Marrack PC: A cell line that can induce thymocyte positive selection. Nature 360:679, 1992
57. Vukamanovic S, Grandea AG, Faas SJ, Knowles BB, Bevan MJ: Positive selection of T-lymphocytes induced by intrathymic injection of a thymic epithelial cell line. Nature 359:729, 1992
58. Chu E, Umetsu D, Rosen F, Geha RS: Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation. J Clin Invest 72:1124, 1983
59. Roncarolo MG, Touraine JL, Banchereau J: Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody. J Clin Invest 77:673, 1986
60. Roncarolo MG, Yssel H, Touraine JL, Bachetta R, Gebuhrer L, de Vries JE, Spits H: Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 158:2139, 1988
61. Roberts JL, Volkman DJ, Buckley RH: Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. J Immunol 143:1575, 1989
62. Geha RS, Rosen FS: The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient. J Immunol 143:84, 1989
63. De Villartay JP, Griscelli C, Fischer A: Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation. Eur J Immunol 16:117, 1986
64. Keever CA, Flomenberg N, Small T, Brochstein JA, Collins N, Young-Yang S, Insel R, Dupont B, O'Reilly RJ: Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency. Hum Immunol 26:27, 1989
65. Keever CA, Flomenberg N, Gazzola MV, Pekle K, Yang SY, Small TN, Collins NH, O'Reilly RJ: Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease. Hum immunol 29:42, 1990
66. Ramsdell FJ, Lantz T, Fowlkes BJ: A nondeletional mechanism of thymic self tolerance. Science 246:1038, 1989
67. Speiser DE, Lees RK, Hengartner H, Zinkernagel RM, MacDonald HR: Positive and negative selection of T cell receptor Vβ domains controlled by distinct cell populations in the thymus. J Exp Med 170:2165, 1989
68. Yoshikai Y, Ogimoto M, Matsuzaki G, Nomoto K: Bone marrow-derived cells are essential for intrathymic deletion of selfreactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras. J Immunol 145:505, 1990
69. Matzinger P, Guerder S: Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74, 1989
70. Schiff SE, Buckley RH: Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras. J Immunol 138:2088, 1987
71. Keever CA, Flomenberg N, Brochstein JA, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ: Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clin Immunol Immunopathol 48:261, 1988
72. Jenkins MK, Johnson JG: Molecules involved in T-cell costimulation. Curr Opin Immunol 5:361, 1993